Main > > >URTICARIA. *

---

Derma.>Urticaria. Chronic Idiopathic Urticaria. TREAT.: OmalizuMAb
for SubCutaneous Use.
The new use is for people 12 years of age and older who remain symptomatic despite treatment with H1-antihistamine therapy.
USA Approval Date: 2014.03.21.
(*) Companies; Patents; TradeMark & Web-
Site Available on Request
UpDate: 2017. 11.28.


>URTICARIA. *'s products
This section has no products